« Back
Home /
6α-hydroxy Paclitaxel

6α-hydroxy Paclitaxel

Item no.	TMO-T36896-5mg
Manufacturer	TargetMol
CASRN	153212-75-0
Amount	5mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitor
Specific against	other
Purity	0,98
Smiles	O(C(C)=O)[C@]12[C@]3([C@H](OC(=O)C4=CC=CC=C4)[C@@]5(O)C(C)(C)C([C@@H](OC(C)=O)C(=O)[C@]3(C)[C@@H](O)[C@H](O)[C@]1(OC2)[H])=C(C)[C@@H](OC([C@@H]([C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)O)=O)C5)[H]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Short Description	6α-hydroxy Paclitaxel is a primary metabolite of the anticancer compound paclitaxel , produced by the action of the cytochrome P450 isoform CYP2C8. The generation of 6α-hydroxy paclitaxel by CYP2C8 can be impacted by other drugs or dietary components that interefere with CYP2C8 activity, as well as by CYP2C8 genetic polymorphisms.
Shipping	cool pack
Storage	-20°
Molecular Weight	869, 91

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

available

Delivery expected until 8/30/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail